Rani Therapeutics Holdings Inc RANI:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 1:43 PM EDT
11.80quote price arrow down-0.20 (-1.67%)
Volume
16,384
52 week range
8.00 - 36.27
Loading...
  • Open12.16
  • Day High12.31
  • Day Low11.52
  • Prev Close12.00
  • 52 Week High36.27
  • 52 Week High Date11/15/21
  • 52 Week Low8.00
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap580.09M
  • Shares Out49.16M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-25.08

KEY STATS

  • Open12.16
  • Day High12.31
  • Day Low11.52
  • Prev Close12.00
  • 52 Week High36.27
  • 52 Week High Date11/15/21
  • 52 Week Low8.00
  • 52 Week Low Date06/14/22
  • Market Cap580.09M
  • Shares Out49.16M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-25.08

RATIOS/PROFITABILITY

  • EPS (TTM)-0.41
  • P/E (TTM)-28.89
  • Fwd P/E (NTM)-4.77
  • EBITDA (TTM)-59.709M
  • ROE (TTM)-
  • Revenue (TTM)1.96M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-3,126.87%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date09/14/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Rani Therapeutics Holdings Inc

There is no recent news for this security.

Profile

MORE
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company. The Company’s technologies enable the development of orally administered biologics. The Company has developed a drug-agnostic oral delivery platform, the RaniPill capsule, which delivers any drug, including molecules, such as peptides, proteins and antibodies. The RaniPill capsule delivers up to a three micrograms (mg) dose of the drug with high bioavailability. Its capsule includes a coating that...
Mir Imran
Executive Chairman of the Board
Talat Imran
Chief Executive Officer, Director
Svai Sanford
Chief Financial Officer
Eric Groen
General Counsel
Address
2051 Ringwood Avenue
San Jose, CA
95131
United States

Top Peers

SYMBOLLASTCHG%CHG
DYN
Dyne Therapeutics Inc
11.19-0.25-2.23%
KNTE
Kinnate Biopharma Inc
14.44+1.26+9.56%
TCDA
Tricida Inc
10.43-0.43-3.96%
JANX
Janux Therapeutics Inc
13.95+0.11+0.79%
AVTE
Aerovate Therapeutics Inc
24.02-0.98-3.92%